The bivalent vaccine, made by U.S. drug company Moderna, targets both the original and Omicron variants of the virus
Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.made by U.S. drug company Moderna conditional approval as a booster for adults on Monday.
Moderna said in June trial data showed that when given as a fourth dose, the variant-adapted shot raised virus-neutralizing antibodies by eightfold against Omicron. “What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: